Top headlines of 2021: Coffee and CV health, vaccine-related myocarditis and more
Healio and Cardiology Today have aggregated a list of the most-read news in cardiology of 2021.
Readers were interested in the effects of antihypertensive drugs on memory decline; the USPSTF advisory against aspirin for primary prevention in those aged 60 years or more; the impact of coffee on CV health; and more.
Certain antihypertensive drugs yield less memory decline in older adults
Older adults who received antihypertensive drugs that crossed the blood-brain barrier demonstrated improved memory recall compared with those who received other types of antihypertensive drugs, according to new results. Read more
USPSTF advises against aspirin for primary CVD prevention for adults 60 years or older
The U.S. Preventive Services Task Force no longer recommends aspirin for primary CVD prevention in adults aged 60 years or older, according to a draft recommendation. Read more
Myocarditis after COVID-19 vaccination infrequent; signals observed in young men
In two studies from Israel published in The New England Journal of Medicine, incidence of myocarditis after COVID-19 vaccination remained low; however, almost all documented cases were in young men. Read more
Higher coffee consumption could confer reduced HF risk
Increased coffee consumption was associated with reduced risk for HF in three different cohorts, according to results published in Circulation: Heart Failure. Read more
Simple food swaps may lower stroke risk
Higher intake of vegetable fat, polyunsaturated fat and vegetable oil could reduce risk for stroke among healthy adults, whereas high intake of nondairy animal fat, total red meat and processed red meat may drive stroke risk, data show. Read more
Daily walnut consumption lowers total cholesterol, LDL at 2 years
Healthy older adults who consumed walnuts daily for 2 years experienced reductions in total cholesterol and LDL, as well as small and total LDL particles, according to results of the WAHA trial. Read more
In omega-3 fatty acid trials, EPA alone yields greater CV risk reduction vs. EPA plus DHA
In a meta-analysis of omega-3 fatty acid trials, eicosapentaenoic acid monotherapy yielded the greatest reduction in CV risk vs. a combination of eicosapentaenoic acid and docosahexaenoic acid. Read more
Sacubitril/valsartan receives expanded indication, including for some with HFpEF
Novartis announced the FDA has granted an expanded indication for sacubitril/valsartan to lower risk for CV death and HF hospitalization in adult patients with chronic HF. Read more
Coffee, green tea consumption beneficial for CVD prevention
Coffee and green tea consumption may be beneficial for CVD prevention, according to study data published in Stroke. Read more
Poor sleep efficiency, longer wake up associated with increased CVD risk
Individuals with poorer sleep efficiency and longer time spent awake from sleep onset to final awakening had increased risk for incident CVD, according to results published in the Journal of the American Heart Association. Read more